BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17912457)

  • 1. Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells.
    Deissler H; Kuhn EM; Lang GE; Deissler H
    Int J Mol Med; 2007 Nov; 20(5):643-52. PubMed ID: 17912457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin.
    Cook GA; Wilkinson DA; Crossno JT; Raghow R; Jennings LK
    Exp Cell Res; 1999 Sep; 251(2):356-71. PubMed ID: 10471321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
    Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
    Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: Impact on tumor cell motility.
    Rana S; Claas C; Kretz CC; Nazarenko I; Zoeller M
    Int J Biochem Cell Biol; 2011 Jan; 43(1):106-19. PubMed ID: 20937409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway.
    Kotha J; Longhurst C; Appling W; Jennings LK
    Exp Cell Res; 2008 May; 314(8):1811-22. PubMed ID: 18358474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.
    Deissler H; Deissler H; Lang S; Lang GE
    Br J Ophthalmol; 2008 Jun; 92(6):839-43. PubMed ID: 18511543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis.
    Ishii M; Iwai K; Koike M; Ohshima S; Kudo-Tanaka E; Ishii T; Mima T; Katada Y; Miyatake K; Uchiyama Y; Saeki Y
    J Bone Miner Res; 2006 Jun; 21(6):965-76. PubMed ID: 16753027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells.
    Murayama Y; Shinomura Y; Oritani K; Miyagawa J; Yoshida H; Nishida M; Katsube F; Shiraga M; Miyazaki T; Nakamoto T; Tsutsui S; Tamura S; Higashiyama S; Shimomura I; Hayashi N
    J Cell Physiol; 2008 Jul; 216(1):135-43. PubMed ID: 18247373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells.
    Castro-Sanchez L; Soto-Guzman A; Navarro-Tito N; Martinez-Orozco R; Salazar EP
    Eur J Cell Biol; 2010 Nov; 89(11):843-52. PubMed ID: 20709424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoylation supports the association of tetraspanin CD63 with CD9 and integrin alphaIIbbeta3 in activated platelets.
    Israels SJ; McMillan-Ward EM
    Thromb Res; 2010 Feb; 125(2):152-8. PubMed ID: 19640571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD9 expression on lymphatic vessels in head and neck mucosa.
    Erovic BM; Neuchrist C; Kandutsch S; Woegerbauer M; Pammer J
    Mod Pathol; 2003 Oct; 16(10):1028-34. PubMed ID: 14559986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha2beta1 integrin controls association of Rac with the membrane and triggers quiescence of endothelial cells.
    Cailleteau L; Estrach S; Thyss R; Boyer L; Doye A; Domange B; Johnsson N; Rubinstein E; Boucheix C; Ebrahimian T; Silvestre JS; Lemichez E; Meneguzzi G; Mettouchi A
    J Cell Sci; 2010 Jul; 123(Pt 14):2491-501. PubMed ID: 20592186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
    De Bruyne E; Andersen TL; De Raeve H; Van Valckenborgh E; Caers J; Van Camp B; Delaissé JM; Van Riet I; Vanderkerken K
    Leukemia; 2006 Oct; 20(10):1870-9. PubMed ID: 16900214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
    Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
    Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of murine retinal endothelial cells.
    Su X; Sorenson CM; Sheibani N
    Mol Vis; 2003 May; 9():171-8. PubMed ID: 12740568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD9 participates in endothelial cell migration during in vitro wound repair.
    Klein-Soyer C; Azorsa DO; Cazenave JP; Lanza F
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):360-9. PubMed ID: 10669631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy.
    Kamisasanuki T; Tokushige S; Terasaki H; Khai NC; Wang Y; Sakamoto T; Kosai K
    Biochem Biophys Res Commun; 2011 Sep; 413(1):128-35. PubMed ID: 21875571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRP-1/CD9 gene transduction downregulates Wnt signal pathways.
    Huang CL; Liu D; Masuya D; Kameyama K; Nakashima T; Yokomise H; Ueno M; Miyake M
    Oncogene; 2004 Sep; 23(45):7475-83. PubMed ID: 15334057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.